Cargando…

Trimetazidine in heart failure with preserved ejection fraction: a randomized controlled cross‐over trial

AIMS: Impaired myocardial energy homeostasis plays an import role in the pathophysiology of heart failure with preserved ejection fraction (HFpEF). Left ventricular relaxation has a high energy demand, and left ventricular diastolic dysfunction has been related to impaired energy homeostasis. This s...

Descripción completa

Detalles Bibliográficos
Autores principales:	van de Bovenkamp, Arno A., Geurkink, Kiki T. J., Oosterveer, Frank T.P., de Man, Frances S., Kok, Wouter E.M., Bronzwaer, Patrick N.A., Allaart, Cor P., Nederveen, Aart J., van Rossum, Albert C., Bakermans, Adrianus J., Handoko, M. Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10567667/ https://www.ncbi.nlm.nih.gov/pubmed/37530098 http://dx.doi.org/10.1002/ehf2.14418

Ejemplares similares

TrimetaziDine as a Performance-enhancING drug in heart failure with preserved ejection fraction (DoPING-HFpEF): rationale and design of a placebo-controlled cross-over intervention study
por: van de Bovenkamp, A. A., et al.
Publicado: (2020)

Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
por: van de Bovenkamp, Arno A., et al.
Publicado: (2021)

How to diagnose heart failure with preserved ejection fraction: the value of invasive stress testing
por: Huis in ’t Veld, A. E., et al.
Publicado: (2016)

Dynamic magnetic resonance measurements of calf muscle oxygenation and energy metabolism in peripheral artery disease
por: Bakermans, Adrianus J., et al.
Publicado: (2019)

Human Cardiac (31)P-MR Spectroscopy at 3 Tesla Cannot Detect Failing Myocardial Energy Homeostasis during Exercise
por: Bakermans, Adrianus J., et al.
Publicado: (2017)

Assessment of left ventricular ejection fraction in patients eligible for ICD therapy: Discrepancy between cardiac magnetic resonance imaging and 2D echocardiography
por: de Haan, S., et al.
Publicado: (2014)

CardioMEMS: the next revolution in heart failure management?
por: Handoko, M. L., et al.
Publicado: (2019)

Trimetazidine in Heart Failure
por: Shu, Hongyang, et al.
Publicado: (2021)

Cardiac Effects of Trimetazidine in Diabetic Rats
por: Mansur, Alfredo J.
Publicado: (2019)

Marathon running transiently depletes the myocardial lipid pool
por: Aengevaeren, Vincent L., et al.
Publicado: (2020)

A 72-channel receive array coil allows whole-heart cine MRI in two breath holds
por: Klarenberg, Hugo, et al.
Publicado: (2022)

A comparison of myocardial magnetic resonance extracellular volume mapping at 3 T against histology of tissue collagen in severe aortic valve stenosis and obstructive hypertrophic cardiomyopathy
por: Bakermans, Adrianus J., et al.
Publicado: (2023)

Right Ventricular and Right Atrial Function Are Less Compromised in Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction: A Comparison With Pulmonary Arterial Hypertension With Similar Pressure Overload
por: van Wezenbeek, Jessie, et al.
Publicado: (2021)

Meta-analysis of trimetazidine treatment for cardiomyopathy
por: Fan, Qian, et al.
Publicado: (2018)

Vectorial wall shear stress calculations in vessel structures using 4D PC-MRI
por: Potters, Wouter V, et al.
Publicado: (2012)

Trimetazidine in Practice: Review of the Clinical and Experimental Evidence
por: Dézsi, Csaba A.
Publicado: (2016)

The cardioprotective role of trimetazidine on cisplatin-induced cardiotoxicity
por: Küçük, Murathan, et al.
Publicado: (2020)

Trimetazidine-Induced Parkinsonism: A Systematic Review
por: Dy, Anna Marielle B., et al.
Publicado: (2020)

Quantitative MRI Reveals Microstructural Changes in the Upper Leg Muscles After Running a Marathon
por: Hooijmans, Melissa T., et al.
Publicado: (2020)

Antipsychotic-Like Effect of Trimetazidine in a Rodent Model
por: Erbaş, Oytun, et al.
Publicado: (2013)

Metabolic manipulation in Dilated Cardiomyopathy: assessing the role of trimetazidine
por: Kapoor, Aditya, et al.
Publicado: (2015)

The effects of trimetazidine on lipopolysaccharide-induced oxidative stress in mice
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2011)

Metabolic manipulation in dilated cardiomyopathy: Assessing the role of trimetazidine
por: Jatain, Suman, et al.
Publicado: (2016)

Clinical effects of carvedilol and trimetazidine for the treatmentof alcoholic myocardiopathy
por: Li, Hui, et al.
Publicado: (2016)

Is Treatment with Trimetazidine Beneficial in Patients with Chronic Heart Failure?
por: Zhou, Xiang, et al.
Publicado: (2014)

The effect of oral and intraurethral trimetazidine use on urethral healing
por: Ayyildiz, Ali, et al.
Publicado: (2016)

Trimetazidine Use in Parkinson’s Disease: Is It a Resolved Problem?
por: Pintér, Dávid, et al.
Publicado: (2021)

Subclinical effects of long‐chain fatty acid β‐oxidation deficiency on the adult heart: A case‐control magnetic resonance study
por: Knottnerus, Suzan J. G., et al.
Publicado: (2020)

Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine
por: Khanra, Sourav, et al.
Publicado: (2023)

Wall shear stress vectors derived from 3D PC-MRI at increasing resolutions in an intracranial aneurysm phantom
por: van Ooij, Pim, et al.
Publicado: (2012)

Effects of trimetazidine in patients with severe chronic heart failure with reduced left ventricular ejection fraction: A prospective, randomized, open-label, cross-over study
por: Bohdan, Michał, et al.
Publicado: (2022)

On the Performance of Trimetazidine and Vitamin E as Pharmacoprotection Agents in Cyclosporin A-Induced Toxicity
por: Cristina, De la Cruz Rodríguez Lilia, et al.
Publicado: (2013)

Trimetazidine for prevention of induced ischemia and reperfusion of guinea pig retina
por: Demir, T, et al.
Publicado: (2010)

Cardioprotective Effects of Atorvastatin plus Trimetazidine in Percutaneous Coronary Intervention
por: Lin, Xuefeng, et al.
Publicado: (2013)

Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine
por: Ferraro, Elisabetta, et al.
Publicado: (2016)

Effects of Trimetazidine on T Wave Alternans in Stable Coronary Artery Disease
por: Yaman, Mehmet, et al.
Publicado: (2016)

Economic evaluation of trimetazidine in the management of chronic stable angina in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2016)

The Impact of Trimetazidine on Disease Severity and Quality of Life in Parkinson’s Disease
por: Pintér, Dávid, et al.
Publicado: (2020)

Protective effect of trimetazidine in radiation-induced cardiac fibrosis in mice
por: Zhang, Jinmeng, et al.
Publicado: (2020)

Neuroprotective effects of combined trimetazidine and progesterone on cerebral reperfusion injury
por: Dhote, Vipin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fm2tcqg29flfe55kmbnihhqsg4